Home
Stocks Trading
Analyst Snapshot
Financial Scores
Market Summary

Protalix BioTherapeutics Inc (AMEX: PLX)

Examining PLX’s book value per share for the latest quarter

September 18, 2025

Kenneth Phillips

Protalix BioTherapeutics Inc (PLX)’s stock has witnessed a price declined of -0.80% from the previous close with its current price ...

most recent

Stocks Trading

Is OLLI’s price to cash per share ratio a concern for investors?

Market Summary

AA’s price-to-book ratio: An indicator of the company’s performance

Financial Scores

AZTA’s price-to-free cash flow ratio: How it affects investment decisions

Analyst Snapshot

What is EB’s price-to-sales ratio telling us about the company’s value?

Stocks Trading

Understanding VIST’s financial ratios: A beginner’s guide

Market Summary

PII’s price-to-cash ratio: Is it a good investment at the moment?

Who We Are

Fueled by a passion for truth since 1992, US Post News brings you trustworthy journalism. Our team of investigators, photographers, and writers delivers fresh news you can rely on. We started with ink and screens, but today we’re a web leader, illuminating the world with verified information.

Company

About US
Contact Us
Disclaimer
Privacy Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Search for:

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled